SHIEF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Shield Therapeutics (SHIEF) Ownership - Who owns Shield Therapeutics?

Shield Therapeutics PLC is a commercial stage specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals that address areas of high unmet medical need... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Northern Design Centre

Phone

+44 1915118500

Employees

Web

https://www.shieldtherapeutics.com

Details

Group

Domestic Stock Funds

Fundamentals

SHIEF

Capitalization

98.5M

P/E Ratio

N/A

Risk (Beta)

0.16

Dividend Yield

N/A

Total Cash

2.4M

Total Cash/Share

0.00

Total Debt

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.02%

Revenue

3.07M

ROE

N/A

Book Value

32.6M

P/B Ratio

12.77

Cash Flow

N/A

Earnings

-0.1

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

3.24M

Current Ratio

2.60

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-21.41M

Float

N/A

Float - Current

N/A

Gross Income Margin

52.62

Revenue To Assets

-54.03

Shares Held By Institutions

4.88M

Shares Outstanding - Current

713M

Total Liabilities

3.25M

Total Volume MTD

N/A

Value

-1

Gain YTD

-1.449

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsOther